Filing Signals

Source: SEC EDGAR Compiled 2026-08-23 04:41 UTC Unattended

← All events

KALA BIO, Inc.

CIK 1479419 KALA·Pharmaceutical Preparations · All EDGAR filings ↗

Late filing Filing comparison

KALA BIO, Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results.

(the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Form 10-Q”) within the prescribed time period because the Company requires additional time to complete its analysis and disclosure regarding its liquidity and capital resources. The Company anticipates that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.
Evidence
Anticipates significant change
False
Other periodic reports filed
True
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Form 10-Q”) within the prescribed time period because the Company requires additional time to complete its analysis and disclosure regarding its liquidity and capital resources. The Company anticipates that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.